Finance

Lists
PHARMA:KLSE
Pharmaniaga Bhd
MYR 0,92
-0,54%
(-0,0050) 1D
9 Okt., 15:09:38 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for PHARMA...
Open
MYR 0,92
High
MYR 0,93
Low
MYR 0,91
Mkt. cap
1,20 mjd
Avg. vol.
2,33 m
Volume
1,72 m
Dividend
1,89%
Quarterly dividend
MYR 0,00
Ex-dividend date
14 Sep. 2026
P/E ratio
17,18
52-wk high
MYR 1,70
52-wk low
MYR 0,91
EPS
MYR 0,05
Shares outstanding
1,31 mjd
No. of employees
4 k
Open
MYR 0,92
High
MYR 0,93
Low
MYR 0,91
Mkt. cap
1,20 mjd
Avg. vol.
2,33 m
Volume
1,72 m
Dividend
1,89%
Quarterly dividend
MYR 0,00
Ex-dividend date
14 Sep. 2026
P/E ratio
17,18
52-wk high
MYR 1,70
52-wk low
MYR 0,91
EPS
MYR 0,05
Shares outstanding
1,31 mjd
No. of employees
4 k
News stories
From web sources and news partners
Profile
Pharmaniaga Berhad is Malaysia’s largest listed integrated healthcare company, offering research and development, manufacturing, logistics, and distribution of pharmaceuticals and medical supplies. Wikipedia
About Pharmaniaga Bhd
CEOZulkarnain Md Eusope
Employees3,5 k
Founded1994
Headquarters-
SectorHealth care provider
Websitepharmaniaga.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Revenue
Net income
All values in MYR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,01 mjd
938,28 m
1,18 mjd
1,04 mjd
Cost of goods sold
911,96 m
841,28 m
1,05 mjd
939,04 m
Cost of revenue
911,96 m
841,28 m
1,05 mjd
939,04 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73,17 m
48,05 m
73,51 m
75,89 m
Operating expense
73,17 m
73,67 m
73,51 m
75,89 m
Total operating expenses
985,13 m
914,96 m
1,12 mjd
1,01 mjd
Operating income
22,13 m
23,32 m
55,02 m
26,10 m
Other non operating income
482,00 k
-2,18 m
92,00 k
107,00 k
EBT including unusual items
10,36 m
11,44 m
46,41 m
17,81 m
EBT excluding unusual items
10,36 m
11,18 m
46,41 m
17,81 m
Income tax expense
2,87 m
2,71 m
14,22 m
4,78 m
Effective tax rate
27,67%
23,69%
30,64%
26,87%
Other operating expenses
-
-
-
-
Net income
7,28 m
7,70 m
31,47 m
12,49 m
Net profit margin
0,72%
0,82%
2,67%
1,20%
Earnings per share
-
-
-
-
Interest and investment income
2,39 m
2,20 m
1,38 m
1,79 m
Interest expense
-14,65 m
-12,17 m
-10,08 m
-10,19 m
Net interest expenses
-12,26 m
-9,96 m
-8,70 m
-8,40 m
Depreciation and amortization charges
-
19,12 m
-
-
EBITDA
30,71 m
30,81 m
64,67 m
32,51 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme